BNTX - Moderna leads COVID-19 vaccine developers; Test makers trade higher amid pandemic concerns

gopixa/iStock via Getty Images Many of the coronavirus test makers and vaccine developers are trading higher in morning hours while the U.S. stocks have trended lower amid concerns over a spike in COVID-19 infections and deaths across the country after weeks of decline. Moderna ([[MRNA]] +6.5%) has gained further in value after reaching a peak on Friday on the prospects of becoming a component in the S&P 500 Index. Other COVID-19 vaccine developers are also among gainers today: BioNTech ([[BNTX]] +2.0%), Novavax ([[NVAX]] +7.2%), Ocugen ([[OCGN]] +8.6%), Inovio ([[INO]] +3.5%), Vaxart ([[VXRT]] +5.0%) Many COVID-19 test makers are also in the green too: Quidel ([[QDEL]] +4.0%), OPKO Health ([[OPK]] +1.4%), Hologic ([[HOLX]] +1.1%), QIAGEN ([[QGEN]] +2.7%), Quest Diagnostics ([[DGX]] +1.2%), Abbott Laboratories ([[ABT]] +1.1%), Hologic ([[HOLX]] +1.1%) This week, Abbott and Johnson & Jonson are likely to indicate the durability of their COVID-related benefit on financials when the two companies

For further details see:

Moderna leads COVID-19 vaccine developers; Test makers trade higher amid pandemic concerns